Chugai Pharmaceutic-Unsp ADRCHGCY
13F holders, Q1 2026 (March 31)13holders
2new positions
2sold out
$27.42avg. 13F price*
At the end of Q1 2026, 13 institutions reported holding Chugai Pharmaceutic-Unsp ADR (CHGCY) in their 13F filings, unchanged from Q4 2025. 2 opened new positions and 2 sold out. The largest holders were Confluence Investment Management LLC ($1.3M), Rhumbline Advisers ($1.3M) and Sterling Capital Management LLC ($1.1M).
- Company
- Chugai Pharmaceutic-Unsp ADR
- CUSIP
- 171269103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $4K |
| Exits | 2 | $7K |
All 13F filers, Q4 2025 → Q1 2026: 6,217 shares bought and 4,482 shares sold, net +1,735 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 13 holders
| Confluence Investment Management LLC | 0.02% | Add +3.8% | 47,100 | $1.3M |
| Rhumbline Advisers | 0.00% | Add +6.0% | 47,019 | $1.3M |
| Sterling Capital Management LLC | 0.02% | Reduce -8.4% | 40,326 | $1.1M |
| GAMMA Investing LLC | 0.02% | Add +8.3% | 13,691 | $377K |
| PNC Financial Services Group, Inc. | 0.00% | Reduce -1.9% | 10,353 | $285K |
| Riverbridge Partners LLC | 0.01% | No change | 7,825 | $215K |
| Salomon & Ludwin, LLC | 0.00% | Add +115.4% | 1,243 | $36K |
| Ancora Advisors LLC | 0.00% | Reduce -17.7% | 1,074 | $30K |
| Thurston, Springer, Miller, Herd & Titak, Inc. | 0.00% | No change | 256 | $7K |
| Hantz Financial Services, Inc. | 0.00% | Reduce -29.0% | 211 | $6K |
| First Command Advisory Services, Inc. | 0.00% | New | 122 | $3K |
| IMA Advisory Services, Inc. | 0.00% | Reduce -15.8% | 32 | $880 |
| Richardson Financial Services Inc. | 0.00% | New | 13 | $358 |
"% of holder's portfolio" is CHGCY's weight in each manager's 13F, not the share of Chugai Pharmaceutic-Unsp ADR the manager owns.